-

Statement from Biocom California and MassBio on America’s Biotechnology Leadership and National Security

SOUTH SAN FRANCISCO, Calif. & LOS ANGELES & SAN DIEGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--The following statement can be attributed to Joe Panetta, Biocom California’s president and CEO, and Kendalle Burlin O’Connell, Massachusetts Biotechnology Council’s (MassBio) CEO and president.

“We strongly support efforts to continue American leadership in the biotechnology sector. We must look at ways to expand domestic capabilities for pharmaceutical research and manufacturing to ensure patient access to innovative medicines often developed by smaller companies that are most reliant on federal grants or contracts. We know that a strong American biotechnology sector is a key national security asset and will continue to work with policymakers and industry leaders to accomplish our shared goals of promoting access to innovation for American patients while protecting our national security.”

About Biocom California

Biocom California is the leader and advocate for California’s life science sector. We work on behalf of more than 1,700 members to drive public policy, build an enviable network of industry leaders, create access to capital, introduce cutting-edge STEM education programs and create robust value-driven purchasing programs.

Founded in 1995 in San Diego, Biocom California provides the strongest public voice to research institutions and companies that fuel the local and state-wide economy. Our goal is simple: to help our members produce novel solutions that improve the human condition. In addition to our San Diego headquarters, Biocom California operates core offices in Los Angeles and the San Francisco Bay Area, with satellite offices in Sacramento, Washington, D.C. and Tokyo. Our broad membership benefits apply to biotechnology, pharmaceutical, medical device, genomics and diagnostics companies of all sizes, as well as to research universities and institutes, clinical research organizations, investors and service providers.

For more information on Biocom California, please visit our website at www.biocom.org. Connect with us on LinkedIn, Facebook, and X.

About MassBio

MassBio’s mission is to advance Massachusetts’ leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. MassBio represents the premier global life sciences and healthcare hub, with 1,600+ members dedicated to preventing, treating, and curing diseases through transformative science and technology that brings value and hope to patients. Founded in 1985, MassBio works to advance policy and promote education, while providing member programs, events, industry thought leadership, and services for the #1 life sciences cluster in the world.

For more information on MassBio, please visit our website at www.massbio.org. Connect with us on LinkedIn, X, Instagram, and MB Vision, our online video library.

Contacts

Biocom California
Carolyn Hawley
Inizio Evoke Comms
(619) 849-5382
Carolyn.hawley@inizioevoke.com

MassBio
Ryan Boehm
ryan.boehm@massbio.org
(617) 702-6302

Biocom California LogoBiocom California Logo

Biocom California


Release Versions

Contacts

Biocom California
Carolyn Hawley
Inizio Evoke Comms
(619) 849-5382
Carolyn.hawley@inizioevoke.com

MassBio
Ryan Boehm
ryan.boehm@massbio.org
(617) 702-6302

Social Media Profiles
More News From Biocom California

Section 232 Pharmaceutical Tariffs - Biocom Statement

SOUTH SAN FRANCISCO, Calif. & LOS ANGELES & SAN DIEGO--(BUSINESS WIRE)--Biocom, the largest life science membership association, representing companies across California and major life science markets, issued the following statement in response to the recent tariffs on patented pharmaceuticals and their ingredients under Section 232 of the Trade Expansion Act. This statement may be attributed to Tim Scott, president and CEO of Biocom: Biocom shares the Administration’s interest in protecting ou...

Biocom Appoints New Members to Its Board of Directors

SOUTH SAN FRANCISCO, Calif. & LOS ANGELES & SAN DIEGO--(BUSINESS WIRE)--Biocom, the largest life science membership association, representing companies across California and major life science markets, today announced the appointment of Aaron K. Cohen, vice president, government affairs and public policy at Neurocrine Biosciences and Bradley Wolff, senior managing director at Evercore, to its board of directors. “Mr. Cohen and Mr. Wolff are valuable additions to our board of directors, which co...

Biocom and Octane Announce Strategic Partnership to Accelerate Innovation Across California’s Life Science and Medtech Ecosystems

SAN DIEGO & NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Biocom, the largest life science membership association, representing companies across California and major life science markets, and Octane, a leading accelerator and innovation platform for technology and medtech companies, today announced a strategic partnership to expand access to capital, accelerator programs and industry networks for life science and medtech companies across California and key life science ecosystems. Through this partne...
Back to Newsroom